$72.5 Million is the total value of ACT CAPITAL MANAGEMENT, LLC's 71 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXSM | New | AXSOME THERAPEUTICS INC | $3,257,000 | – | 73,000 | +100.0% | 4.50% | – |
| New | ADTRAN HOLDINGS INC | $2,937,000 | – | 150,000 | +100.0% | 4.05% | – | |
| VRNA | New | VERONA PHARMAsponsored ads | $1,467,000 | – | 143,500 | +100.0% | 2.02% | – |
| CMBM | New | CAMBIUM NETWORKS CORPORATION | $582,000 | – | 34,400 | +100.0% | 0.80% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $522,000 | – | 12,500 | +100.0% | 0.72% | – |
| DEN | New | DENBURY INC COM | $345,000 | – | 4,000 | +100.0% | 0.48% | – |
| SQ | New | BLOCK INCcl a | $330,000 | – | 6,000 | +100.0% | 0.46% | – |
| CHK | New | CHESAPEAKE ENERGY CORP | $236,000 | – | 2,500 | +100.0% | 0.33% | – |
| New | RUMBLE INC | $234,000 | – | 19,100 | +100.0% | 0.32% | – | |
| SNOW | New | SNOWFLAKE INCcl a | $170,000 | – | 1,000 | +100.0% | 0.24% | – |
| SAVA | New | CASSAVA SCIENCES INC | $142,000 | – | 3,400 | +100.0% | 0.20% | – |
| New | CELLECTAR BIOSCIENCES INC | $73,000 | – | 21,750 | +100.0% | 0.10% | – | |
| New | SYROS PHARMACEUTICALS INC | $23,000 | – | 3,499 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 6 | Q3 2022 | 22.7% |
| ARROWHEAD PHARMACEUTICALS INC | 6 | Q3 2022 | 10.1% |
| ARCTURUS THERAPEUTICS HLDGS | 6 | Q3 2022 | 12.8% |
| CLEARSIDE BIOMEDICAL INC | 6 | Q3 2022 | 7.7% |
| KRYSTAL BIOTECH INC | 6 | Q3 2022 | 5.6% |
| FUBOTV INC | 6 | Q3 2022 | 4.4% |
| EIGER BIOPHARMACEUTICALS INC | 6 | Q3 2022 | 2.4% |
| ASPIRA WOMENS HEALTH INC | 6 | Q3 2022 | 3.3% |
| ICAD INC | 6 | Q3 2022 | 2.0% |
| INHIBIKASE THERAPEUTICS INC COM | 6 | Q3 2022 | 1.7% |
View ACT CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HyreCar Inc. | December 09, 2020 | 230,000 | 1.3% |
| SOLIGENIX, INC. | February 07, 2020 | 1,221,499 | 5.6% |
| EDISON NATION, INC. | April 18, 2019 | 214,454 | 3.8% |
| Hancock Jaffe Laboratories, Inc. | December 26, 2018 | 503,500 | 4.3% |
| Ampio Pharmaceuticals, Inc. | August 10, 2018 | 1,210,785 | 1.4% |
| Xspand Products Lab, Inc. | May 09, 2018 | 405,000 | 9.3% |
| CROSSROADS SYSTEMS INC | June 16, 2017 | 59,053 | 4.8% |
| ALLDIGITAL HOLDINGS, INC.Sold out | January 23, 2017 | 0 | 0.0% |
| MOBIVITY HOLDINGS CORP. | January 06, 2017 | 1,734,916 | 4.8% |
| Akers Biosciences Inc | January 25, 2016 | 213,500 | 3.9% |
View ACT CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-16 |
| 13F-HR | 2021-08-16 |
| SC 13G/A | 2020-12-09 |
| SC 13G/A | 2020-02-10 |
| SC 13G/A | 2020-02-07 |
| SC 13G/A | 2020-02-07 |
View ACT CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.